Childhood Apraxia of Speech: A Descriptive and Prescriptive Model of Assessment and Diagnosis
Abstract
:1. Introduction
1.1. Introduction to Childhood Apraxia of Speech
1.2. Defining Childhood Apraxia of Speech
1.3. Neurological Foundations of Childhood Apraxia of Speech
1.4. Diagnostic Tools for Childhood Apraxia of Speech
1.5. Tools for Assessing Childhood Apraxia of Speech
1.6. Rationale
1.7. Purpose of the Present Study
2. Methods
2.1. Sampling
“childhood apraxia of speech” (Title) or “developmental apraxia of speech” (Title) or “articulatory apraxia” (Title) or “developmental verbal dyspraxia” (Title) or “verbal dyspraxia” (Title) or “childhood dyspraxia” (Title)
2.2. Design
2.3. Measures
2.4. Reliability, Validity, and Trustworthiness
2.5. Procedure
3. Results
3.1. Cluster Analysis
3.2. Thematic Analysis
No. | Citation | Aim | Findings | Diagnostic and Assessment Measures |
---|---|---|---|---|
1 | [40] | The study aimed to distinguish children with developmental apraxia of speech (DAS) from those with speech delay (SD) by identifying reliable differences in their speech error profiles. | The study supported the differentiation of suspected DAS from SD based on speech error profiles, providing evidence for the clinical utility of the DAS diagnostic category. | A local ascertainment study was utilized, examining speech error profiles for diagnostic markers. |
2 | [41] | The objective was to characterize patients with developmental verbal dyspraxia (DVD) and investigate its genetic underpinnings, particularly the absence of a paternal FOXP2 gene. | The absence of paternal FOXP2 was identified as the cause of DVD in patients, implicating the parent-of-origin expression of FOXP2 in human speech development. | Diagnostic assessment included the characterization of DVD in the context of FOXP2 gene deletions or disruptions and maternal uniparental disomy of chromosome 7. |
3 | [42] | The study’s primary aim was to scrutinize the differences in speech/language and written language skills between children with suspected CAS and children with other speech sound disorders at school age. | Children with suspected CAS demonstrated persistent difficulties in syllable sequencing, nonsense word repetition, and language abilities and were at risk for reading and spelling problems. | Speech and language assessments, including articulation, diadochokinesis, language, reading, and spelling measures, were conducted. |
4 | [28] | The study aimed to identify objective measures that could differentiate children with suspected CAS from those with other speech disorders. | A combination of measures including syllable segregation and lexical stress matches achieved a high diagnostic accuracy for CAS, suggesting oral–motor examination and polysyllabic production accuracy as key diagnostic tools. | The diagnostic measures included perceptual CAS features, polysyllabic picture-naming tasks, and oral–motor examinations including diadochokinesis. |
5 | [43] | The study hypothesized that the speech disorder observed in individuals with galactosemia may fulfil the diagnostic criteria for CAS. | The prevalence of CAS in participants with galactosemia was found to be significantly higher than in the general population, indicating a potential genetic risk factor for motor speech disorders. | Participants underwent a comprehensive assessment that included cognitive, structural, sensorimotor, language, speech, prosody, and voice evaluations. |
6 | [44] | The study investigated whether the core phenotype of CAS includes deficits in auditory perceptual encoding, memory, and transcoding processes. | The study concluded that individuals with CAS exhibit deficits across encoding, memory, and transcoding, with the SRT showing a moderate diagnostic accuracy for identifying these deficits. | The Syllable Repetition Task (SRT) was used to assess speech processing competencies including encoding, memory, and transcoding. |
7 | [16] | The research aimed to delineate determiners for the differential diagnosis of developmental apraxia of speech (DAS) by analyzing the symptoms consistently used for diagnosis. | Only a fraction of children referred for DAS were confirmed with the diagnosis, highlighting the necessity for distinct features in differential diagnosis. | Longitudinal phonological and language evaluation data were analyzed to identify critical features for differential diagnosis. |
8 | [45] | The study sought to identify the criteria speech–language pathologists use to diagnose developmental apraxia of speech (DAS). | A small set of characteristics such as inconsistent productions and oral–motor difficulties were commonly used for diagnosis, demonstrating ambiguity in the criteria for DAS. | A survey capturing the diagnostic criteria used by clinicians, with the identification of the characteristics most frequently associated with DAS. |
9 | [46] | This research aimed to test the efficacy of a treatment targeting dysprosody in children with CAS, particularly the control of syllable durations in lexical stress. | All participating children showed improvements in controlling syllable duration for lexical stress patterns, with some generalization to untreated stimuli, supporting the treatment’s efficacy. | An intensive treatment trial using principles of motor learning (PML) to target syllable duration control in nonwords with varying stress patterns. |
10 | [47] | The study assessed the efficacy of treatment for young children with severe CAS using a dynamic temporal and tactile cueing approach based on motor learning principles. | Rapid changes in speech performance following treatment were observed, suggesting the effectiveness of intensive and frequent motor learning-based therapy. | A single-subject multiple-baseline design across behaviors with continuous data collection was employed to evaluate the treatment approach. |
11 | [48] | The study compared the effects of random versus blocked practice schedules in CAS treatment to evaluate their impact on speech motor learning. | The results were mixed, with some children showing a preference for blocked practice and others for random practice, indicating variability in the efficacy of practice schedules. | An alternating-treatment single-subject design with multiple baselines across behaviors was used to compare random and blocked practice within the dynamic temporal and tactile cueing treatment. |
12 | [49] | The objective was to systematically review the treatment outcomes for children with CAS, evaluating the evidence for various therapeutic approaches. | Several treatments showed positive responses, with three approaches demonstrating sufficient evidence for Phase III trials and clinical practice. | A systematic review of treatment studies, including single-case experimental designs and case series, analyzed for improvement rate differences and effect sizes. |
13 | [50] | The study aimed to validate the hypothesis that inappropriate stress is a reliable marker for differentiating children with DAS from those with speech delay (SD). | A significant number of children with suspected DAS exhibited inappropriate stress, suggesting it as a diagnostic marker for a DAS subtype. | Cross-validation of stress findings using conversational speech samples from multiple diagnostic facilities and comparison with speech delay profiles. |
14 | [51] | The study aimed to link the symptoms of CAS to specific information processing deficits using computational neural modeling. | The model suggested that key symptoms of CAS could be due to a reliance on feedback control caused by poor feed-forward commands. | Computational modeling with the DIVA (Directions Into Velocities of Articulators) model to simulate speech production deficits in CAS. |
15 | [52] | The research aimed to validate a lexical stress marker for childhood apraxia of speech (sAOS) using acoustic correlates of stress in bisyllabic word forms. | The lexical stress ratio (LSR) successfully differentiated children with sAOS from those with speech delay (SD), supporting its diagnostic utility. | Analysis of lexical stress task responses, with the development of a composite lexical stress ratio (LSR) as a potential diagnostic marker |
16 | [53] | The aim was to investigate whether inappropriate stress patterns could serve as a diagnostic marker to differentiate suspected DAS from SD in children. | Inappropriate stress was confirmed as a distinguishing feature in some children with suspected DAS, proposing it as a potential diagnostic marker. | Comparative analysis of speech and prosody–voice profiles between children with suspected DAS and those with SD. |
17 | [29] | The study aimed to compare the efficacy of the Rapid Syllable Transition (ReST) treatment to the Nuffield Dyspraxia Programme-Third Edition (NDP3) for children with CAS. | Both ReST and NDP3 demonstrated large treatment effects, with ReST showing superior maintenance post treatment and both showing significant generalization. | A randomized controlled trial evaluating articulation and prosodic accuracy before and after treatment interventions. |
18 | [54] | The study explored the significance of production frequency in speech therapy for CAS and its impact on motor learning and generalization. | A higher production frequency in treatment led to faster target acquisition and better generalization, emphasizing its importance in therapy for CAS. | An alternating treatment AB design comparing different production frequencies in speech therapy sessions. |
19 | [55] | The purpose was to deepen the understanding of the underlying deficits in DAS, particularly the planning/programming of speech movements in context, by analyzing coarticulation patterns. | Children with DAS displayed more variability in coarticulation, less distinction between vowels, and idiosyncratic patterns, suggesting deficits in speech movement planning. | Second formant frequency measurements were conducted in repetitions of nonsense utterances to analyze coarticulation. |
20 | [56] | This study aimed to uncover the neurobiological basis of speech disorders and the potential genetic contributions, focusing on FOXP2 associations. | A novel small intragenic FOXP2 deletion was identified in a child with severe motor speech disorder, suggesting a genetic basis for speech disorders, including CAS. | Genetic screening for variants in the FOXP2 gene among probands with speech disorder and their families. |
21 | [57] | The study aimed to examine the speech characteristics of patients treated for galactosemia and search for the presence of verbal dyspraxia. | A high percentage of galactosemia patients exhibited verbal dyspraxia, indicating a specific speech disorder associated with this metabolic condition. | Assessment of speech characteristics in patients treated for galactosemia to identify the prevalence of verbal dyspraxia. |
22 | [58] | The research sought to determine if speech inconsistency is a unique feature of CAS and if it can differentiate CAS from speech delay. | Speech inconsistency was found to be a core feature of CAS, with its measurement varying depending on the stimuli used. | Assessment of speech inconsistency at phonemic and token-to-token levels using a variety of stimuli to diagnose CAS. |
23 | [20] | The study aimed to use whole-exome sequencing to explore the genetic heterogeneity in CAS. | The findings supported genetic heterogeneity in CAS, with several clinically reportable variants in the genes associated with CAS and related disorders. | Whole-exome sequencing to identify clinically reportable variants in the genes associated with CAS in a small cohort. |
24 | [59] | The study’s goal was to define the phenotype associated with 12p13.33 microdeletion, which includes ELKS/ERC1, and investigate its link with CAS. | Deletion in the 12p13.33 locus, including the ELKS/ERC1 gene, was associated with CAS, suggesting a genetic basis for speech sound disorders. | Array CGH to identify subtelomeric and interstitial rearrangements, with the clinical assessment of speech and neurobehavioral development. |
25 | [60] | The purpose was to examine the impact of feedback frequency on treatment for CAS and its role in motor learning and treatment efficacy. | Mixed results were observed, indicating that the benefits of feedback frequency alterations in CAS treatment may vary among individuals. | An alternating-treatment single-subject design with multiple baselines across behaviors to compare high-frequency and low-frequency feedback. |
No. | Citation | Aim | Findings | Diagnostic and Assessment Measures |
---|---|---|---|---|
1 | [37] | This study aimed to investigate the relationship between gluten sensitivity and neurotransmitter alterations (glutamate and GABA) in children with CAS. | Children with CAS showed higher levels of antigliadin IgA and glutamate, with a lower level of GABA, indicating a possible diagnostic marker for CAS relating to gluten sensitivity and neurotransmitter imbalance. | Plasma levels of antigliadin IgA, glutamate, and GABA were determined by enzyme-linked immunosorbent assay (ELISA) in children with CAS, DLD, and NT. |
2 | [61] | The purpose was to identify early indicators of CAS in late talkers and provide general guidelines for intervention. | Varying responses to intervention among late talkers suggested potential early indicators of CAS, influencing diagnostic decisions and the early implementation of motor learning principles in treatment. | Implementation of the Target Word program and focused stimulation, along with parental guidance for stimulating language development. |
3 | [62] | The study aimed to validate the Multilevel Word Accuracy Composite Scale (MACS) as a novel measure of speech production in children with CAS. | The MACS showed positive correlations with established speech accuracy measures and demonstrated moderate-to-excellent reliability among expert raters and SLPs. | Utilization of the MACS to rate speech production accuracy, with reliability and validity tested against established measures. |
4 | [63] | This study explored SLPs’ and OTPs’ perspectives on comorbidity of CAS and sensory processing disorder (SPD) and the effectiveness of interprofessional approaches. | The findings emphasized the need for a unified clinical language and interprofessional approaches to improve treatment for children with CAS and comorbid SPD. | Reflexive thematic analysis of responses from SLPs and OTPs regarding the comorbid presentation and treatment of CAS and SPD. |
5 | [39] | The study investigated the self-reported communication attitudes of children with CAS and their implications for assessment and intervention. | Older children with CAS exhibited more negative communication attitudes, highlighting the importance of including child self-report measures in research and therapy. | Administration of validated communication attitude questionnaires to children with CAS enrolled in an intensive speech-focused intervention. |
6 | [38] | The paper outlined a protocol for a randomized controlled trial comparing the efficacy of DTTC treatment with varying dose frequencies in children with CAS. | The study aimed to provide evidence for the optimal treatment schedule for DTTC by examining treatment outcomes at different dose frequencies. | Randomized controlled trial protocol comparing low versus high dose frequency of DTTC treatment in children with CAS. |
7 | [64] | This research examined manual rhythmic sequencing skills in children with hx/CAS compared to typically developing children. | Children with hx/CAS showed deficits in manual rhythmic sequencing, providing support for a domain-general cognitive mechanisms account of rhythmic deficits in CAS. | Assessment of manual rhythmic sequencing skills using clapping and tapping tasks in children with hx/CAS and TD. |
8 | [65] | The study described the development of self-made gestures as an adaptive communication strategy in an individual with CAS. | The individual with CAS developed self-made gestures for communication that eventually subsided as verbal communication improved, demonstrating an adaptive strategy for coping with expressive challenges. | Observational case study of the development and use of self-made gestures in an individual with CAS. |
9 | [66] | The study aimed to compare the outcomes of two motor-based treatments, ReST and ultrasound biofeedback, for school-age children with CAS. | Both treatments were equally effective, showing significant improvements in speech sound accuracy and prosody, with treatment effects maintained at the 1-month follow-up. | A pilot randomized control trial comparing ReST and ultrasound biofeedback treatment outcomes in children with CAS. |
10 | [67] | The research aimed to examine the clinical practice of CAS in Hong Kong to inform future research and evidence-based practice. | The study found that local SLPs’ understanding of CAS was limited and that evidence for the assessment, diagnosis, and treatment of Cantonese speakers with CAS was lacking. | Web-based survey study on the knowledge and experience of Hong Kong pediatric SLPs with CAS, including assessment, diagnosis, and treatment practices. |
3.3. Categorization of Existing Diagnosis and Assessment Measures of Childhood Apraxia of Speech
3.4. A Conceptual Model Describing and Prescribing Diagnosis and Assessment of Childhood Apraxia of Speech
4. Discussion
4.1. Limitations
4.2. Implications
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- American Speech-Language-Hearing Association Childhood Apraxia of Speech. Available online: https://www.asha.org/practice-portal/clinical-topics/childhood-apraxia-of-speech/#collapse_5 (accessed on 1 March 2024).
- World Health Organization 6A01.0 Developmental Speech Sound Disorder. Available online: https://icd.who.int/browse/2024-01/mms/en#551966778 (accessed on 1 March 2024).
- American Psychiatric Association. F80.0 Speech Sound Disorder. In Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR; American Psychiatric Association: Washington, DC, USA, 2022. [Google Scholar]
- American Psychological Association Developmental Apraxia of Speech (DAS). Available online: https://dictionary.apa.org/developmental-apraxia-of-speech (accessed on 1 March 2024).
- Chilosi, A.M.; Lorenzini, I.; Fiori, S.; Graziosi, V.; Rossi, G.; Pasquariello, R.; Cipriani, P.; Cioni, G. Behavioral and Neurobiological Correlates of Childhood Apraxia of Speech in Italian Children. Brain Lang. 2015, 150, 177–185. [Google Scholar] [CrossRef]
- Oliveira, A.M.d.; Nunes, I.; Cruz, G.S.d.; Gurgel, L.G. Métodos de Avaliação da Apraxia de Fala Na Infância: Revisão Sistemática. Audiol.-Commun. Res. 2021, 26, e2524. [Google Scholar] [CrossRef]
- Murray, E.; Iuzzini-Seigel, J.; Maas, E.; Terband, H.; Ballard, K.J. Differential Diagnosis of Childhood Apraxia of Speech Compared to Other Speech Sound Disorders: A Systematic Review. Am. J. Speech Lang. Pathol. 2021, 30, 279–300. [Google Scholar] [CrossRef] [PubMed]
- Aziz, A.A.; Shohdi, S.; Osman, D.M.; Habib, E.I. Childhood Apraxia of Speech and Multiple Phonological Disorders in Cairo-Egyptian Arabic Speaking Children: Language, Speech, and Oro-Motor Differences. Int. J. Pediatr. Otorhinolaryngol. 2010, 74, 578–585. [Google Scholar] [CrossRef] [PubMed]
- McNeill, B.C.; Gillon, G.T.; Dodd, B. Phonological Awareness and Early Reading Development in Childhood Apraxia of Speech (CAS). Int. J. Lang. Commun. Disord. 2009, 44, 175–192. [Google Scholar] [CrossRef] [PubMed]
- Nijland, L.; Terband, H.; Maassen, B. Cognitive Functions in Childhood Apraxia of Speech. J. Speech Lang. Hear. Res. 2015, 58, 550–565. [Google Scholar] [CrossRef] [PubMed]
- Morgan, A.T.; Vogel, A.P. Intervention for Childhood Apraxia of Speech. Cochrane Database Syst. Rev. 2008, 3, CD006278. [Google Scholar] [CrossRef] [PubMed]
- Morgan, A.T.; Murray, E.; Liégeois, F.J. Interventions for Childhood Apraxia of Speech. Cochrane Database Syst. Rev. 2018, 5, CD006278. [Google Scholar] [CrossRef] [PubMed]
- Tierney, C.D.; Pitterle, K.; Kurtz, M.; Nakhla, M.; Todorow, C. Bridging the Gap Between Speech and Language: Using Multimodal Treatment in a Child with Apraxia. Pediatrics 2016, 138, e20160007. [Google Scholar] [CrossRef]
- Raca, G.; Baas, B.S.; Kirmani, S.; Laffin, J.J.; Jackson, C.A.; Strand, E.A.; Jakielski, K.J.; Shriberg, L.D. Childhood Apraxia of Speech (CAS) in Two Patients with 16p11.2 Microdeletion Syndrome. Eur. J. Hum. Genet. 2013, 21, 455–459. [Google Scholar] [CrossRef]
- Zuk, J.; Iuzzini-Seigel, J.; Cabbage, K.; Green, J.R.; Hogan, T.P. Poor Speech Perception Is Not a Core Deficit of Childhood Apraxia of Speech: Preliminary Findings. J. Speech Lang. Hear. Res. 2018, 61, 583–592. [Google Scholar] [CrossRef] [PubMed]
- Davis, B.L.; Jakielski, K.J.; Marquardt, T.P. Developmental Apraxia of Speech: Determiners of Differential Diagnosis. Clin. Linguist. Phon. 1998, 12, 25–45. [Google Scholar] [CrossRef]
- Josephs, K.A.; Duffy, J.R.; Strand, E.A.; Machulda, M.M.; Senjem, M.L.; Master, A.V.; Lowe, V.J.; Jack, C.R.; Whitwell, J.L. Characterizing a Neurodegenerative Syndrome: Primary Progressive Apraxia of Speech. Brain 2012, 135, 1522–1536. [Google Scholar] [CrossRef] [PubMed]
- Josephs, K.A. Clinicopathological and Imaging Correlates of Progressive Aphasia and Apraxia of Speech. Brain 2006, 129, 1385–1398. [Google Scholar] [CrossRef] [PubMed]
- Chilosi, A.M.; Podda, I.; Ricca, I.; Comparini, A.; Franchi, B.; Fiori, S.; Pasquariello, R.; Casalini, C.; Cipriani, P.; Santorelli, F.M. Differences and Commonalities in Children with Childhood Apraxia of Speech and Comorbid Neurodevelopmental Disorders: A Multidimensional Perspective. J. Pers. Med. 2022, 12, 313. [Google Scholar] [CrossRef]
- Worthey, E.A.; Raca, G.; Laffin, J.J.; Wilk, B.M.; Harris, J.M.; Jakielski, K.J.; Dimmock, D.P.; Strand, E.A.; Shriberg, L.D. Whole-Exome Sequencing Supports Genetic Heterogeneity in Childhood Apraxia of Speech. J. Neurodev. Disord. 2013, 5, 29. [Google Scholar] [CrossRef] [PubMed]
- Morgan, A.T.; Webster, R. Aetiology of Childhood Apraxia of Speech: A Clinical Practice Update for Paediatricians. J. Paediatr. Child Health 2018, 54, 1090–1095. [Google Scholar] [CrossRef]
- Swartz, M.T.; Koenig, L.; Hitchcock, E.R. Acoustic Analysis of Vowel Production in Children with Childhood Apraxia of Speech. J. Acoust. Soc. Am. 2022, 151, A44–A45. [Google Scholar] [CrossRef]
- Miller, H.E.; Guenther, F.H. Modelling Speech Motor Programming and Apraxia of Speech in the DIVA/GODIVA Neurocomputational Framework. Aphasiology 2021, 35, 424–441. [Google Scholar] [CrossRef]
- Cuadros, J.; Z-Rivera, L.; Castro, C.; Whitaker, G.; Otero, M.; Weinstein, A.; Martínez-Montes, E.; Prado, P.; Zañartu, M. DIVA Meets EEG: Model Validation Using Formant-Shift Reflex. Appl. Sci. 2023, 13, 7512. [Google Scholar] [CrossRef]
- Meier, A.M.; Guenther, F.H. Neurocomputational Modeling of Speech Motor Development. J. Child Lang. 2023, 50, 1318–1335. [Google Scholar] [CrossRef] [PubMed]
- Weerathunge, H.R.; Alzamendi, G.A.; Cler, G.J.; Guenther, F.H.; Stepp, C.E.; Zañartu, M. LaDIVA: A Neurocomputational Model Providing Laryngeal Motor Control for Speech Acquisition and Production. PLoS Comput. Biol. 2022, 18, e1010159. [Google Scholar] [CrossRef]
- Shriberg, L.D.; Strand, E.A.; Fourakis, M.; Jakielski, K.J.; Hall, S.D.; Karlsson, H.B.; Mabie, H.L.; McSweeny, J.L.; Tilkens, C.M.; Wilson, D.L. A Diagnostic Marker to Discriminate Childhood Apraxia of Speech from Speech Delay: IV. The Pause Marker Index. J. Speech Lang. Hear. Res. 2017, 60, S1153–S1169. [Google Scholar] [CrossRef]
- Murray, E.; McCabe, P.; Heard, R.; Ballard, K.J. Differential Diagnosis of Children with Suspected Childhood Apraxia of Speech. J. Speech Lang. Hear. Res. 2015, 58, 43–60. [Google Scholar] [CrossRef] [PubMed]
- Murray, E.; McCabe, P.; Ballard, K.J. A Randomized Controlled Trial for Children with Childhood Apraxia of Speech Comparing Rapid Syllable Transition Treatment and the Nuffield Dyspraxia Programme-Third Edition. J. Speech Lang. Hear. Res. 2015, 58, 669–686. [Google Scholar] [CrossRef]
- Terband, H.; Maassen, B. Speech Motor Development in Childhood Apraxia of Speech: Generating Testable Hypotheses by Neurocomputational Modeling. Folia Phoniatr. Logop. 2010, 62, 134–142. [Google Scholar] [CrossRef]
- Strand, E.A.; Duffy, J.R.; Clark, H.M.; Josephs, K. The Apraxia of Speech Rating Scale: A Tool for Diagnosis and Description of Apraxia of Speech. J. Commun. Disord. 2014, 51, 43–50. [Google Scholar] [CrossRef] [PubMed]
- Shahin, M.; Ahmed, B.; Parnandi, A.; Karappa, V.; McKechnie, J.; Ballard, K.J.; Gutierrez-Osuna, R. Tabby Talks: An Automated Tool for the Assessment of Childhood Apraxia of Speech. Speech Commun. 2015, 70, 49–64. [Google Scholar] [CrossRef]
- Morgan, A.T.; Vogel, A.P. A Cochrane Review of Treatment for Childhood Apraxia of Speech. Eur. J. Phys. Rehabil. Med. 2009, 45, 103–110. [Google Scholar]
- Strand, E.A.; McCauley, R.J.; Weigand, S.D.; Stoeckel, R.E.; Baas, B.S. A Motor Speech Assessment for Children with Severe Speech Disorders: Reliability and Validity Evidence. J. Speech Lang. Hear. Res. 2013, 56, 505–520. [Google Scholar] [CrossRef]
- Chen, C. CiteSpace: A Practical Guide for Mapping Scientific Literature; Nova Science Publishers: New York, NY, USA, 2016; ISBN 9781536102956. [Google Scholar]
- van Eck, N.J.; Waltman, L. VOSviewer Manual: Manual for VOSviewer Version 1.6.18; Univeristeit Leiden: Leiden, The Netherlands, 2022. [Google Scholar]
- Nashaat, N.H.; Elrouby, I.; Zeidan, H.M.; Kilany, A.; Abdelraouf, E.R.; Hashish, A.F.; Abdelhady, H.S.; ElKeblawy, M.M.; Shadi, M.S. Childhood Apraxia of Speech: Exploring Gluten Sensitivity and Changes in Glutamate and Gamma-Aminobutyric Acid Plasma Levels. Pediatr. Neurol. 2024, 151, 104–110. [Google Scholar] [CrossRef] [PubMed]
- Iuzzini-Seigel, J.; Case, J.; Grigos, M.I.; Velleman, S.L.; Thomas, D.; Murray, E. Dose Frequency Randomized Controlled Trial for Dynamic Temporal and Tactile Cueing (DTTC) Treatment for Childhood Apraxia of Speech: Protocol Paper. BMC Pediatr. 2023, 23, 263. [Google Scholar] [CrossRef] [PubMed]
- Keller, S.; Maas, E. Self-Reported Communication Attitudes of Children with Childhood Apraxia of Speech: An Exploratory Study. Am. J. Speech Lang. Pathol. 2023, 32, 1806–1824. [Google Scholar] [CrossRef] [PubMed]
- Shriberg, L.D.; Aram, D.M.; Kwiatkowski, J. Developmental Apraxia of Speech.1. Descriptive and Theoretical Perspectives. J. Speech Lang. Hear. Res. 1997, 40, 273–285. [Google Scholar] [CrossRef] [PubMed]
- Feuk, L.; Kalervo, A.; Lipsanen-Nyman, M.; Skaug, J.; Nakabayashi, K.; Finucane, B.; Hartung, D.; Innes, M.; Kerem, B.; Nowaczyk, M.J.; et al. Absence of a Paternally Inherited FOXP2 Gene in Developmental Verbal Dyspraxia. Am. J. Hum. Genet. 2006, 79, 965–972. [Google Scholar] [CrossRef] [PubMed]
- Lewis, B.A.; Freebairn, L.A.; Hansen, A.J.; Iyengar, S.K.; Taylor, H.G. School-Age Follow-up of Children with Childhood Apraxia of Speech. Lang. Speech Hear. Serv. Sch. 2004, 35, 122–140. [Google Scholar] [CrossRef]
- Shriberg, L.D.; Potter, N.L.; Strand, E.A. Prevalence and Phenotype of Childhood Apraxia of Speech in Youth with Galactosemia. J. Speech Lang. Hear. Res. 2011, 54, 487–519. [Google Scholar] [CrossRef] [PubMed]
- Shriberg, L.D.; Lohmeier, H.L.; Strand, E.A.; Jakielski, K.J. Encoding, Memory, and Transcoding Deficits in Childhood Apraxia of Speech. Clin. Linguist. Phon. 2012, 26, 445–482. [Google Scholar] [CrossRef] [PubMed]
- Forrest, K. Diagnostic Criteria of Developmental Apraxia of Speech Used by Clinical Speech-Language Pathologists. Am. J. Speech Lang. Pathol. 2003, 12, 376–380. [Google Scholar] [CrossRef]
- Ballard, K.J.; Robin, D.A.; McCabe, P.; McDonald, J. A Treatment for Dysprosody in Childhood Apraxia of Speech. J. Speech Lang. Hear. Res. 2010, 53, 1227–1245. [Google Scholar] [CrossRef]
- Strand, E.A.; Stoeckel, R.; Baas, B. Treatment of Severe Childhood Apraxia of Speech: A Treatment Efficacy Study. J. Med. Speech Lang. Pathol. 2006, 14, 297–307. [Google Scholar]
- Maas, E.; Farinella, K.A. Random Versus Blocked Practice in Treatment for Childhood Apraxia of Speech. J. Speech Lang. Hear. Res. 2012, 55, 561–578. [Google Scholar] [CrossRef] [PubMed]
- Murray, E.; McCabe, P.; Ballard, K.J. A Systematic Review of Treatment Outcomes for Children with Childhood Apraxia of Speech. Am. J. Speech Lang. Pathol. 2014, 23, 486–504. [Google Scholar] [CrossRef] [PubMed]
- Shriberg, L.D.; Aram, D.M.; Kwiatkowski, J. Developmental Apraxia of Speech: III. A Subtype Marked by Inappropriate Stress. J. Speech Lang. Hear. Res. 1997, 40, 313–337. [Google Scholar] [CrossRef] [PubMed]
- Terband, H.; Maassen, B.; Guenther, F.H.; Brumberg, J. Computational Neural Modeling of Speech Motor Control in Childhood Apraxia of Speech (CAS). J. Speech Lang. Hear. Res. 2009, 52, 1595–1609. [Google Scholar] [CrossRef] [PubMed]
- Shriberg, L.D.; Campbell, T.F.; Karlsson, H.B.; Brown, R.L.; Mcsweeny, J.L.; Nadler, C.J. A Diagnostic Marker for Childhood Apraxia of Speech: The Lexical Stress Ratio. Clin. Linguist. Phon. 2003, 17, 549–574. [Google Scholar] [CrossRef] [PubMed]
- Shriberg, L.D.; Aram, D.M.; Kwiatkowski, J. Developmental Apraxia of Speech: 2. Toward a Diagnostic Marker. J. Speech Lang. Hear. Res. 1997, 40, 286–312. [Google Scholar] [CrossRef] [PubMed]
- Edeal, D.M.; Gildersleeve-Neumann, C.E. The Importance of Production Frequency in Therapy for Childhood Apraxia of Speech. Am. J. Speech Lang. Pathol. 2011, 20, 95–110. [Google Scholar] [CrossRef] [PubMed]
- Nijland, L.; Maassen, B.; Van der Meulen, S.; Gabreëls, F.; Kraaimaat, F.W.; Schreuder, R. Coarticulation Patterns in Children with Developmental Apraxia of Speech. Clin. Linguist. Phon. 2002, 16, 461–483. [Google Scholar] [CrossRef]
- Turner, S.J.; Hildebrand, M.S.; Block, S.; Damiano, J.; Fahey, M.; Reilly, S.; Bahlo, M.; Scheffer, I.E.; Morgan, A.T. Small Intragenic Deletion in FOXP2 Associated with Childhood Apraxia of Speech and Dysarthria. Am. J. Med. Genet. A 2013, 161, 2321–2326. [Google Scholar] [CrossRef]
- Nelson, C.D.; Waggoner, D.D.; Donnell, G.N.; Tuerck, J.M.; Buist, N.R.M. Verbal Dyspraxia in Treated Galactosemia. Pediatrics 1991, 88, 346–350. [Google Scholar] [CrossRef]
- Iuzzini-Seigel, J.; Hogan, T.P.; Green, J.R. Speech Inconsistency in Children with Childhood Apraxia of Speech, Language Impairment, and Speech Delay: Depends on the Stimuli. J. Speech Lang. Hear. Res. 2017, 60, 1194–1210. [Google Scholar] [CrossRef] [PubMed]
- Thevenon, J.; Callier, P.; Andrieux, J.; Delobel, B.; David, A.; Sukno, S.; Minot, D.; Mosca Anne, L.; Marle, N.; Sanlaville, D.; et al. 12p13.33 Microdeletion Including ELKS/ERC1, a New Locus Associated with Childhood Apraxia of Speech. Eur. J. Hum. Genet. 2013, 21, 82–88. [Google Scholar] [CrossRef]
- Maas, E.; Butalla, C.E.; Farinella, K.A. Feedback Frequency in Treatment for Childhood Apraxia of Speech. Am. J. Speech Lang. Pathol. 2012, 21, 239–257. [Google Scholar] [CrossRef] [PubMed]
- Baixauli, I.; Senent-Capuz, N. Early Indicators of Childhood Apraxia of Speech in Late Talkers: General Guidelines to Intervention|Indicadores Tempranos de Dispraxia Verbal En El Inicio Tardío: Orientaciones Para La Intervención Inmaculada. Medicina 2024, 84, 65–71. [Google Scholar] [PubMed]
- Case, J.; Wang, E.W.; Grigos, M.I. The Multilevel Word Accuracy Composite Scale: A Novel Measure of Speech Production in Childhood Apraxia of Speech. Am. J. Speech Lang. Pathol. 2023, 32, 1866–1883. [Google Scholar] [CrossRef]
- Friedman, Z.L.; Nealon, K. Siloed vs. Interprofessional Approach: Speech Language Pathologists’ and Occupational Therapists’ Perspectives on Comorbidity of Childhood Apraxia of Speech and Sensory Processing Disorder. J. Interprof. Educ Pr. 2023, 31, 100611. [Google Scholar] [CrossRef]
- Vuolo, J.; Kinross, A.; DeHart, K. Manual Rhythmic Sequencing Skills in Children with Childhood Apraxia of Speech. J. Speech Lang. Hear. Res. 2023, 66, 3773–3790. [Google Scholar] [CrossRef]
- Funayama, M.; Nakajima, A. Development of Self-Made Gestures as an Adaptive Strategy for Communication in an Individual with Childhood Apraxia of Speech. Cogn. Behav. Neurol. 2023, 36, 249–258. [Google Scholar] [CrossRef]
- McCabe, P.; Preston, J.L.; Evans, P.; Heard, R. A Pilot Randomized Control Trial of Motor-Based Treatments for Childhood Apraxia of Speech: Rapid Syllable Transition Treatment and Ultrasound Biofeedback. Am. J. Speech Lang. Pathol. 2023, 32, 613–628. [Google Scholar] [CrossRef]
- Wong, E.C.H.; Wong, M.N.; Velleman, S.L. Clinical Practice of Childhood Apraxia of Speech in Hong Kong: A Web-Based Survey Study. PLoS ONE 2023, 18, 0284109. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. International Classification of Functioning, Disability and Health; World Health Organization: Geneva, Switzerland, 2001. [Google Scholar]
- McKechnie, J.; Shahin, M.; Ahmed, B.; McCabe, P.; Arciuli, J.; Ballard, K.J. An Automated Lexical Stress Classification Tool for Assessing Dysprosody in Childhood Apraxia of Speech. Brain Sci. 2021, 11, 1408. [Google Scholar] [CrossRef] [PubMed]
- Terband, H.; Namasivayam, A.; Maas, E.; van Brenk, F.; Mailend, M.-L.; Diepeveen, S.; van Lieshout, P.; Maassen, B. Assessment of Childhood Apraxia of Speech: A Review/Tutorial of Objective Measurement Techniques. J. Speech Lang. Hear. Res. 2019, 62, 2999–3032. [Google Scholar] [CrossRef] [PubMed]
Cluster ID | Size | Silhouette | Label (LSI) | Label (LLR) | Label (MI) | Average Year |
---|---|---|---|---|---|---|
0 | 63 | 0.725 | childhood apraxia | developmental apraxia | speech part ii (1.91) | 2002 |
1 | 48 | 0.696 | childhood apraxia | tabby talk | AAC intervention (0.88) | 2009 |
2 | 45 | 0.779 | childhood apraxia | mental retardation | childhood apraxia (0.22) | 2010 |
3 | 45 | 0.739 | childhood apraxia | underlying speech processes | pathogenic role (0.72) | 2015 |
4 | 41 | 0.832 | childhood apraxia | breakpoint localization | pathogenic role (0.33) | 2009 |
5 | 35 | 0.79 | childhood apraxia | speech characteristics | pathogenic role (1.11) | 2012 |
6 | 31 | 0.755 | childhood apraxia | functional characteristics | pathogenic role (0.25) | 2009 |
7 | 26 | 0.92 | childhood apraxia | clinical practice | childhood apraxia (0.25) | 2012 |
8 | 26 | 0.933 | developmental verbal dyspraxia | 11p13 locus | childhood apraxia (0.27) | 2007 |
9 | 24 | 0.819 | childhood apraxia | treatment outcome | tablet-based delivery (0.3) | 2013 |
No. | Category | Elaboration | How Studies Accounted for the Category | Sample Studies |
---|---|---|---|---|
1 | Neurobiological Markers | Examining the biochemical and genetic underpinnings of CAS to aid in diagnosis. | Studies measured specific biomarkers, such as neurotransmitter levels or gene mutations, which may be linked to the etiology of CAS. | [37,41] |
2 | Speech Motor Control | Assessing speech production and motor planning as a diagnostic measure for CAS. | Utilized tasks and tools that measure the accuracy and consistency of speech motor control, often comparing performance between CAS and typically developing children. | [40,64] |
3 | Perceptual Speech Features | Identifying perceptual characteristics of speech that are indicative of CAS. | Studies relied on expert judgment and perceptual rating scales to distinguish CAS from other speech disorders. | [28,29,62] |
4 | Auditory Processing | Exploring the role of auditory perception and encoding in CAS. | Investigated how children with CAS perceive and encode auditory information, and whether deficits in these areas can be diagnostic markers. | [42,44] |
5 | Prosody and Stress Patterns | Focusing on the rhythmic and intonational aspects of speech that are often disrupted in CAS. | Studies examined specific prosodic features, such as lexical stress, to differentiate CAS from other speech disorders. | [43,64] |
6 | Parent- and Self-Report Measures | Using subjective reports from parents and individuals with CAS to inform diagnosis and treatment. | Studies included questionnaires or interviews that captured the lived experience and communicative challenges faced by those with CAS. | [39,52] |
7 | Intervention Response | Assessing changes in speech following specific therapeutic interventions as a diagnostic tool. | Evaluated how children with suspected CAS respond to targeted speech therapy as a means of confirming diagnosis. | [61,66] |
8 | Motor Learning and Generalization | Observing the ability to learn and generalize motor patterns as characteristic of CAS. | Studies focused on the application of motor learning principles in assessment and treatment to determine the ability to generalize learned speech patterns. | [38,60] |
9 | Comorbidity Analysis | Investigating the co-occurrence of CAS with other developmental disorders. | Explored how the presence of other conditions, such as sensory processing disorder, may influence the diagnosis and treatment of CAS. | [53,63] |
10 | Cultural and Linguistic Considerations | Considering the influence of language and culture on the assessment and diagnosis of CAS. | Studies acknowledged the need for culturally and linguistically appropriate diagnostic measures for CAS, especially in multilingual contexts. | [59,67] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alduais, A.; Alfadda, H. Childhood Apraxia of Speech: A Descriptive and Prescriptive Model of Assessment and Diagnosis. Brain Sci. 2024, 14, 540. https://doi.org/10.3390/brainsci14060540
Alduais A, Alfadda H. Childhood Apraxia of Speech: A Descriptive and Prescriptive Model of Assessment and Diagnosis. Brain Sciences. 2024; 14(6):540. https://doi.org/10.3390/brainsci14060540
Chicago/Turabian StyleAlduais, Ahmed, and Hind Alfadda. 2024. "Childhood Apraxia of Speech: A Descriptive and Prescriptive Model of Assessment and Diagnosis" Brain Sciences 14, no. 6: 540. https://doi.org/10.3390/brainsci14060540
APA StyleAlduais, A., & Alfadda, H. (2024). Childhood Apraxia of Speech: A Descriptive and Prescriptive Model of Assessment and Diagnosis. Brain Sciences, 14(6), 540. https://doi.org/10.3390/brainsci14060540